Document Classification

Section Type: RESULTS

Text: The rates of venous thromboembolism were 0. 18 and 0. 32 event per 100 person-years of follow-up in the rosuvastatin and placebo groups, respectively (hazard ratio with rosuvastatin, 0. 57 ; 95 % confidence interval [CI], 0. 37 to 0. 86 ; P = 0. 007) ; the corresponding rates for unprovoked venous thromboembolism (i. e., occurring in the absence of a known malignant condition, trauma, hospitalization, or surgery) were 0. 10 and 0. 17 (hazard ratio, 0. 61 ; 95 % CI, 0. 35 to 1. 09 ; P = 0. 09) and for provoked venous thromboembolism (i. e., occurring in patients with cancer or during or shortly after trauma, hospitalization, or surgery), 0. 08 and 0. 16 (hazard ratio, 0. 52 ; 95 % CI, 0. 28 to 0. 96 ; P = 0. 03).